Literature DB >> 19007971

Proteomic identification of differentially-expressed proteins in squamous cervical cancer.

Xueqiong Zhu1, Jieqiang Lv, Lirong Yu, Xuejie Zhu, Jieli Wu, Shuangwei Zou, Shanshan Jiang.   

Abstract

OBJECTIVE: To identify candidate biomarkers for squamous cervical cancer as well as reveal the molecular mechanism underlying this disease by a proteomic approach.
METHODS: Proteins from 10 pairs of human squamous cervical cancer and matching adjacent normal cervical tissues were separated by two-dimensional gel electrophoresis and the differentially expressed proteins were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Then, some of the interesting proteins obtained were confirmed by Western blotting in the other 20 pairs of tissues.
RESULTS: A comparison of protein patterns revealed 55 protein spots significantly changed, of which 24 protein spots with concordantly increased and 31 protein spots with concordantly decreased intensity in squamous cervical cancer compared with adjacent normal cervical tissues. Thirty-two of these proteins were identified by mass spectrometry. The overexpression of the Tyk2, S100A9, and Zinc finger protein 217 in squamous cervical cancer was confirmed by immunoblotting.
CONCLUSIONS: Our study suggested that a proteomics-based approach is useful for developing a more complete picture of the protein profile of squamous cervical cancer. Further ongoing analysis of these differential proteins will determine their potential applicability to squamous cervical cancer-specific diagnosis and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007971     DOI: 10.1016/j.ygyno.2008.09.045

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  23 in total

Review 1.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

2.  Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma.

Authors:  Mohd Altaf Najar; Mohammad Arefian; David Sidransky; Harsha Gowda; T S Keshava Prasad; Prashant Kumar Modi; Aditi Chatterjee
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

3.  Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.

Authors:  Enoc M Cortés-Malagón; José Bonilla-Delgado; José Díaz-Chávez; Alfredo Hidalgo-Miranda; Sandra Romero-Cordoba; Aykut Uren; Haydar Celik; Matthew McCormick; José A Munguía-Moreno; Eloisa Ibarra-Sierra; Jaime Escobar-Herrera; Paul F Lambert; Daniel Mendoza-Villanueva; Rosa M Bermudez-Cruz; Patricio Gariglio
Journal:  Virology       Date:  2013-09-27       Impact factor: 3.616

Review 4.  How to evaluate emerging technologies in cervical cancer screening?

Authors:  Marc Arbyn; Guglielmo Ronco; Jack Cuzick; Nicolas Wentzensen; Philip E Castle
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

5.  Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.

Authors:  Shuangwei Zou; Qi Shen; Ying Hua; Wenxiao Jiang; Wenwen Zhang; Xueqiong Zhu
Journal:  Reprod Sci       Date:  2013-04-18       Impact factor: 3.060

Review 6.  Review of S100A9 biology and its role in cancer.

Authors:  Joseph Markowitz; William E Carson
Journal:  Biochim Biophys Acta       Date:  2012-11-01

7.  Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo.

Authors:  Xuechao Jia; Chuntian Huang; Yamei Hu; Qiong Wu; Fangfang Liu; Wenna Nie; Hanyong Chen; Xiang Li; Zigang Dong; Kangdong Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-03-17

8.  Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value.

Authors:  M I Lomnytska; S Becker; I Bodin; A Olsson; K Hellman; A-C Hellström; M Mints; U Hellman; G Auer; S Andersson
Journal:  Br J Cancer       Date:  2010-11-30       Impact factor: 7.640

9.  Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Authors:  Geert Zegels; Geert Aa Van Raemdonck; Wiebren Aa Tjalma; Xaveer Wm Van Ostade
Journal:  Proteome Sci       Date:  2010-12-08       Impact factor: 2.480

10.  Establishing the role of tyrosine kinase 2 in cancer.

Authors:  Caroline Ubel; Stephanie Mousset; Denis Trufa; Horia Sirbu; Susetta Finotto
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.